Delivery Order SPE2DB24D2208-SPE2DB26FHGRC
- Not listed
- The Defense Logistics Agency awarded a $3,201.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on September 10, 2025, with completion targeted for September 11, 2025. This non-competitive delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves military and veteran...
- The Defense Logistics Agency awarded a $2,853.03 delivery order to AmerisourceBergen Drug Corp for Arimidex 1 mg tablets (30-count units) with an ultimate completion date of October 28, 2025. This is a firm fixed-price, non-set-aside contract awarded on October 27, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $27,693.54 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on September 24, 2025, with a completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a competitive delivery order valued at $11,825.31 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) with an ultimate completion date of October 21, 2025. This non-set-aside contract represents a firm fixed-price delivery order under AmerisourceBergen's larger pharmaceutical supply agreement, with performance of work occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a $11,784.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Arimidex 1 mg tablets (30-count supply) with a completion date of June 2, 2025. This non-competitive delivery order was issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,719.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count packages of Arimidex 1 mg tablets. The contract was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025, and represents a non-competitive, non-set-aside transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location at...
- The Defense Logistics Agency awarded a delivery order valued at $2,244.92 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on September 7, 2025, with completion scheduled for September 8, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $5,853.04 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) with a firm fixed price arrangement. The contract, awarded on August 4, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of August 5, 2025. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a $3,036.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count) with a completion date of June 20, 2025. This non-set-aside competitive award was issued on June 18, 2025, with performance to occur at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a...
- SPE2DB24D2208Indefinite Delivery Contract
- SPE2DB24D2208-SPE2DB26FHGRCDelivery Order
The Defense Logistics Agency awarded a $18,725.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Arimidex 1 mg tablets (30-count units). The contract, with an ultimate completion date of October 30, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle that extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain. The company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. This award exemplifies the company's capability to fulfill federal medical supply needs through open competition and demonstrates its role as a key provider within the DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.7k | 10/29/25 |